JP2008513472A5 - - Google Patents

Download PDF

Info

Publication number
JP2008513472A5
JP2008513472A5 JP2007532479A JP2007532479A JP2008513472A5 JP 2008513472 A5 JP2008513472 A5 JP 2008513472A5 JP 2007532479 A JP2007532479 A JP 2007532479A JP 2007532479 A JP2007532479 A JP 2007532479A JP 2008513472 A5 JP2008513472 A5 JP 2008513472A5
Authority
JP
Japan
Prior art keywords
hydrogen
haloalkyl
alkyl
haloalkoxy
halo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007532479A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008513472A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/033051 external-priority patent/WO2006034004A2/en
Publication of JP2008513472A publication Critical patent/JP2008513472A/ja
Publication of JP2008513472A5 publication Critical patent/JP2008513472A5/ja
Pending legal-status Critical Current

Links

JP2007532479A 2004-09-17 2005-09-16 システインプロテアーゼインヒビターの調製のための方法及び中間体 Pending JP2008513472A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61080604P 2004-09-17 2004-09-17
PCT/US2005/033051 WO2006034004A2 (en) 2004-09-17 2005-09-16 Processes and intermediates for preparing cysteine protease inhibitors

Publications (2)

Publication Number Publication Date
JP2008513472A JP2008513472A (ja) 2008-05-01
JP2008513472A5 true JP2008513472A5 (https=) 2008-07-03

Family

ID=35899659

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007532479A Pending JP2008513472A (ja) 2004-09-17 2005-09-16 システインプロテアーゼインヒビターの調製のための方法及び中間体

Country Status (15)

Country Link
US (1) US7737300B2 (https=)
EP (1) EP1799645A2 (https=)
JP (1) JP2008513472A (https=)
KR (1) KR20070061877A (https=)
CN (1) CN101068783A (https=)
AU (1) AU2005287046A1 (https=)
BR (1) BRPI0515470A (https=)
CA (1) CA2580065A1 (https=)
CR (1) CR8993A (https=)
EC (1) ECSP077321A (https=)
IL (1) IL181792A0 (https=)
MX (1) MX2007003118A (https=)
NO (1) NO20071937L (https=)
WO (1) WO2006034004A2 (https=)
ZA (1) ZA200703102B (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1663958E (pt) 2003-09-18 2015-06-01 Virobay Inc Compostos contendo haloalquilo como inibidores de protease de cisteína
EP1819667B1 (en) 2004-12-02 2012-10-17 ViroBay, Inc. Sulfonamide compounds as cysteine protease inhibitors
US7488848B2 (en) 2005-03-21 2009-02-10 Virobay, Inc. Alpha ketoamide compounds as cysteine protease inhibitors
US7893093B2 (en) 2005-03-22 2011-02-22 Virobay, Inc. Sulfonyl containing compounds as cysteine protease inhibitors
WO2008028301A1 (en) * 2006-09-08 2008-03-13 Merck Frosst Canada Ltd. Prodrugs of inhibitors of cathepsin s
US20100048717A1 (en) * 2006-09-25 2010-02-25 MERCK FROSST CANADA LTD, Merk & Co., Inc. Cathepsin b inhibitors
US7893112B2 (en) 2006-10-04 2011-02-22 Virobay, Inc. Di-fluoro containing compounds as cysteine protease inhibitors
EP2079683B1 (en) 2006-10-04 2015-01-21 Virobay, Inc. Di-fluoro containing compounds as cysteine protease inhibitors
CA2672494A1 (en) 2006-12-14 2008-06-19 Nps Pharmaceuticals, Inc. Use of d-serine derivatives for the treatment of anxiety disorders
US8273913B2 (en) 2007-04-02 2012-09-25 Merck Canada Inc. Amidation process for the preparation of cathepsin K inhibitors
JO3032B1 (ar) 2008-10-17 2016-09-05 Xenon Pharmaceuticals Inc مركبات سبيرو – اوكسندول وإستعمالاتها كعوامل علاجية.
US20120101053A1 (en) * 2009-06-22 2012-04-26 Cameron Black Cathepsin cysteine protease inhibitors for the treatment of various diseases
US8324417B2 (en) 2009-08-19 2012-12-04 Virobay, Inc. Process for the preparation of (S)-2-amino-5-cyclopropyl-4,4-difluoropentanoic acid and alkyl esters and acid salts thereof
WO2012119941A1 (en) 2011-03-04 2012-09-13 Prozymex A/S Peptidyl nitrilcompounds as peptidase inhibitors
WO2012174552A2 (en) * 2011-06-17 2012-12-20 Virobay, Inc. Cathepsin inhibitors for treating microglia-mediated neuron loss in the central nervous system
EP3342765B1 (en) * 2015-08-29 2021-09-15 Sunshine Lake Pharma Co., Ltd. Cathepsin k inhibitor and application thereof
CN106478564B (zh) * 2015-08-29 2021-11-12 广东东阳光药业有限公司 组织蛋白酶k抑制剂及其用途
WO2020201572A1 (en) 2019-04-05 2020-10-08 Université De Bretagne Occidentale Protease-activated receptor-2 inhibitors for the treatment of sensory neuropathy induced by a marine neurotoxic poisoning

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9723407D0 (en) * 1997-11-05 1998-01-07 Ciba Geigy Ag Organic compounds
SK6572000A3 (en) * 1997-11-05 2000-10-09 Novartis Ag Dipeptide nitriles, process for the preparation thereof, their use as medicaments and pharmaceutical composition comprising them
JP2002537293A (ja) * 1999-02-20 2002-11-05 アストラゼネカ アクチボラグ カテプシンlおよび/またはカテプシンsの阻害剤としてのアセタミドアセトニトリル誘導体
CA2459825A1 (en) * 2001-10-02 2003-04-10 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as reversible inhibitors of cysteine proteases
CN100430052C (zh) * 2002-03-05 2008-11-05 默克弗罗斯特加拿大有限公司 组织蛋白酶半胱氨酸蛋白酶抑制剂
JP4076955B2 (ja) * 2002-03-11 2008-04-16 花王株式会社 化粧料

Similar Documents

Publication Publication Date Title
JP2008513472A5 (https=)
CY2020012I2 (el) Προφαρμακα των ενωσεων 2,4-πυριμιδινδιαμινης και οι χρησεις αυτων
EP1939199A4 (en) NEW ADENINE CONNECTION
JP2008506632A5 (https=)
JP2009524695A5 (https=)
EP2103619A4 (en) IMIDAZOTHIAZOLDERIVATE
ATE481383T1 (de) 3-aza-bicycloä3.1.0ühexanderivate
BRPI0810646A2 (pt) " compostos farmacêuticos ".
DE602005015215D1 (de) Orthosubstituierte aryl- oder heteroarylamidverbindungen
BRPI0818958A2 (pt) "processos para a fabricação dos hidrofluoroalquenos, para a fabricação dos hidrofluoroalcanóis, para a fabricação dos hidrofluoroésteres e composto"
WO2007048064A3 (en) Amino-pyrimidines as casein kinase ii (ck2) modulators
WO2006058700A8 (en) Acetamide compounds as fungicides
EP1938155A4 (en) BUSINESS PROCESS EXECUTE ENGINE
EP1794167A4 (en) SUBSTITUTED ISOXAZOLE AS FUNGICIDES
WO2009064374A3 (en) Oral formulations of bis(thiohydrazide amides)
JP2007520565A5 (https=)
ATE531717T1 (de) Neue kristalline form eines pyridazinoä4,5- büindolderivats
IT1366567B (it) Granulati espandibili a basemdi polimeri vinilaromatici dotati di migliorata espansibilita'e procedimento per la loro preparazione
EP1945731A4 (en) ADHESIVE AGENTS
NO20054767D0 (no) Sammensetninger omfattende apomorfin for inhalering i lunge
ZA200707933B (en) Substituted aryl 1.4-pyrazine derivatives
PL377747A1 (pl) Synteza amidu kwasu 3-(4-hydroksyfenylo) propanowego
JP2005298393A5 (https=)
JP2005298653A5 (https=)
JP2010504415A5 (https=)